Stuart Cobb - Mar 13, 2024 Form 4 Insider Report for Neurogene Inc. (NGNE)

Role: Chief Scientific Officer
Signature: /s/ Christine Mikail, as attorney-in-fact for Stuart Cobb
Stock symbol: NGNE
Transactions as of: Mar 13, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/14/2024, 08:51 PM
Previous filing: Dec 26, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NGNE	Common Stock	Award	$0	+20.4K		$0.00	20.4K	Mar 13, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NGNE	Stock Option (Right to Buy)	Award	$0	+34.5K		$0.00	34.5K	Mar 13, 2024	Common Stock	34.5K	$36.06	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests as to 1/4 of the total number of shares on March 13, 2025, and then 1/48 of the total number of shares will vest monthly thereafter, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.